AJR Am J Roentgenol

1. DIETRICH CF
   Current Challenges of the Expanding Role of Contrast-Enhanced Ultrasound in Hepatocellular Carcinoma Diagnosis Using LI-RADS.
   AJR Am J Roentgenol. 2025 Jun 4. doi: 10.2214/AJR.25.33329.
   

   >> Share

   
   

   
   Am J Gastroenterol

2. CIRICILLO J, Myer A, Yeboah-Korang A, Osman A, et al
   Improving the Diagnostic Accuracy of RECAM in North American Patients With Suspected Idiosyncratic Drug-Induced Liver Injury.
   Am J Gastroenterol. 2024;120:1325-1333.
   

   >> Share

   
   
3. BARRITT AS 4TH, Hayashi PH, Stolz AA, Barnhart H, et al
   Refinement of Hy Law Using the Drug-Induced Liver Injury Network Database.
   Am J Gastroenterol. 2024;120:1307-1313.
   

   >> Share

   
   
4. HUANG Y, Huang H, Wei T, Zhang A, et al
   Disparities, Trends, and Predictions to 2040 in Gastrointestinal Cancer Incidence, Mortality in the United States.
   Am J Gastroenterol. 2024;120:1367-1380.
   

   >> Share

   
   
5. QIAO Y, Yang L, Yang H, Zheng M, et al
   Longitudinal Associations Between Metabolic Dysfunction-Associated Steatotic Liver Disease and Subclinical Cardiovascular Measures in Chinese Children.
   Am J Gastroenterol. 2024;120:1395-1399.
   

   >> Share

   
   

   
   Biochem Biophys Res Commun

6. NISHI H, Nakanishi S, Yamanaka D, Takahashi SI, et al
   Apolipoprotein b transcription is driven by ornithine in hepatoma cell lines.
   Biochem Biophys Res Commun. 2025;775:152076.
   

   >> Share

   
   
7. HAN Y, Fan J, Xia W, Dong X, et al
   Folic acid-functionalized PLGA nanomedicines encapsulating echinacoside for liver cancer therapy.
   Biochem Biophys Res Commun. 2025;774:152049.
   

   >> Share

   
   

   
   BMC Gastroenterol

8. ZHU H, Zheng M, Li W, Huang Y, et al
   Cholesterol-modified prognostic nutritional index as an independent prognostic biomarker in primary biliary cholangitis patients.
   BMC Gastroenterol. 2025;25:421.
   

   >> Share

   
   
9. TAN H, Xu Y, Zhang C, Zhong K, et al
   Development and validation of a nomogram for predicting early recurrence in patients undergoing different courses of postoperative adjuvant transarterial chemoembolisation.
   BMC Gastroenterol. 2025;25:422.
   

   >> Share

   
   
10. XIA C, Liu Y, Qing X
    Trends in incidence and mortality of early-onset gastrointestinal cancers: a comprehensive study.
    BMC Gastroenterol. 2025;25:424.
    

    >> Share

    
    
11. DAI Y, Zeng M, He H, Cai M, et al
    A risk prediction model for nausea and vomiting after TACE: a cross-sectional study.
    BMC Gastroenterol. 2025;25:427.
    

    >> Share

    
    
12. SUI WF, Duan YX, Cai ZF, Li JY, et al
    Quantitative literature analysis on efficacy and safety of balloon-occluded transarterial chemoembolization for hepatocellular carcinoma.
    BMC Gastroenterol. 2025;25:430.
    

    >> Share

    
    

    
    Clin Res Hepatol Gastroenterol

13. LEE CH, Kang MG, Oh S, Gwak IS, et al
    Hepatocellular carcinoma risk in ICD-coded non-cirrhotic nonalcoholic fatty liver disease refined by fatty liver index: A nationwide South Korean cohort study.
    Clin Res Hepatol Gastroenterol. 2025;49:102612.
    

    >> Share

    
    
14. SAIFI ES, Faita F, Nardin M, Orizio P, et al
    Evaluation of long-term changes in liver function and structure in patients exposed to SARS-CoV-2 infection: A prospective study.
    Clin Res Hepatol Gastroenterol. 2025;49:102606.
    

    >> Share

    
    
15. BEN YEDDER N, Girot P, Koudougou C, Schnee M, et al
    Lack of prior screening for advanced liver fibrosis in patients with newly diagnosed hepatocellular carcinoma: Results from a prospective multicentre study.
    Clin Res Hepatol Gastroenterol. 2025;49:102607.
    

    >> Share

    
    
16. JAIN P, Jain A, Deshmukh R, Samal P, et al
    Metabolic dysfunction-associated steatotic liver disease (MASLD): Exploring systemic impacts and innovative therapies.
    Clin Res Hepatol Gastroenterol. 2025;49:102584.
    

    >> Share

    
    
17. ZHANG C, Sun M, Ding Y, Yuan X, et al
    Research progress on the regulatory role of different cell death pathways in metabolic-dysfunction-associated steatotic liver disease.
    Clin Res Hepatol Gastroenterol. 2025;49:102578.
    

    >> Share

    
    

    
    Dig Dis Sci

18. CHEN F, Zhou Z, Fu J, Gao C, et al
    Selenomethionine Alleviates Alcohol-Induced Liver Injury by Inhibiting Ferroptosis.
    Dig Dis Sci. 2025;70:1779-1787.
    

    >> Share

    
    
19. CAPINHA F, Carvalhana S, Cortez-Pinto H
    Role of Alcohol in Steatotic Liver Disease: Impact on Patients with Cardiometabolic Risk Factors.
    Dig Dis Sci. 2025;70:1746-1756.
    

    >> Share

    
    
20. BELCHER JM
    Predicting the Use of Dialysis for Acute Kidney Injury in Patients with Cirrhosis-Does Diagnosis Matter?
    Dig Dis Sci. 2025 Jun 5. doi: 10.1007/s10620-025-09143.
    

    >> Share

    
    
21. OWAIS M, Kumar D, Anjum A, Kumar J, et al
    Clinical Insights on Characteristics and Outcomes of Hepatocellular Carcinoma in Patients with Autoimmune Hepatitis.
    Dig Dis Sci. 2025 May 31. doi: 10.1007/s10620-025-09124.
    

    >> Share

    
    
22. LIU Y, Mo W, Sun W, Chen J, et al
    NFAT2 Induces Tumor Cell Proliferation and Metastasis by Acting as a Transcriptional Co-activator of the TGF-beta1/SMAD Signaling Pathway and Inducing the Epithelial-Mesenchymal Transition in Liver Cancer.
    Dig Dis Sci. 2025;70:1799-1812.
    

    >> Share

    
    

    
    Eur Radiol

23. GRIGORIADIS A, Bergquist A, Kartalis N
    Shading light in the black box of hepatobiliary imaging.
    Eur Radiol. 2025 Jun 6. doi: 10.1007/s00330-025-11740.
    

    >> Share

    
    
24. PARK R, Kim DH, Choi SH, Kim J, et al
    Preoperative scoring system for predicting microvascular invasion in intrahepatic cholangiocarcinoma using gadoxetate-enhanced MRI.
    Eur Radiol. 2025 Jun 6. doi: 10.1007/s00330-025-11722.
    

    >> Share

    
    
25. ERLEY J, Naimi L, Molwitz I, Aydemir DG, et al
    Novel insights into cardiac structure, function, perfusion, and tissue characteristics in liver cirrhosis: a magnetic resonance analysis.
    Eur Radiol. 2025 Jun 5. doi: 10.1007/s00330-025-11710.
    

    >> Share

    
    

    
    Gut

26. WANG C, Felli E, Fallowfield JA, Dietrich CF, et al
    Vasomics of the liver.
    Gut. 2025;74:1008-1020.
    

    >> Share

    
    
27. LI S, Fu Y, Jia X, Liu Z, et al
    NLRP6 deficiency enhances macrophage-mediated phagocytosis via E-Syt1 to inhibit hepatocellular carcinoma progression.
    Gut. 2025 Jun 5:gutjnl-2024-334448. doi: 10.1136/gutjnl-2024-334448.
    

    >> Share

    
    
28. XING X, Wang SD, Yang JL, Wang Z, et al
    Presinusoidal portal hypertension with cutaneous vascular malformations.
    Gut. 2025 Jun 2:gutjnl-2025-335640. doi: 10.1136/gutjnl-2025-335640.
    

    >> Share

    
    

    
    Hepatology

29. LIANG BG, Zheng YM, Xu MH, Gao C, et al
    The MASTL/YBX1/PAK4 axis regulated by stress-activated STK24 triggers lenvatinib resistance and tumor progression in hepatocellular carcinoma.
    Hepatology. 2025 Jun 2. doi: 10.1097/HEP.0000000000001392.
    

    >> Share

    
    

    
    Indian J Gastroenterol

30. PEMMADA V, Shetty A, Shetty S, C GP, et al
    ABC score is a better predictor for 30-day mortality in upper gastrointestinal bleeding: A prospective single-center study.
    Indian J Gastroenterol. 2024 Dec 19. doi: 10.1007/s12664-024-01703.
    

    >> Share

    
    
31. JOTHIMANI D, Marannan NK, Rela M
    Acute liver failure and liver transplantation.
    Indian J Gastroenterol. 2025;44:298-310.
    

    >> Share

    
    

    
    J Gastroenterol

32. ONO A, Hayes CN, Miura R, Kawaoka T, et al
    Noninvasive prediction of the clinical benefit of immunotherapy in hepatocellular carcinoma.
    J Gastroenterol. 2025 May 30. doi: 10.1007/s00535-025-02251.
    

    >> Share

    
    

    
    J Gastroenterol Hepatol

33. GUO X, Wu L, Lai J, Wu Y, et al
    Causal Associations Between Lipids, NPC1L1, and Liver Cancer Risk: Insights From Mendelian Randomization and Bioinformatics.
    J Gastroenterol Hepatol. 2025;40:1602-1615.
    

    >> Share

    
    
34. XIA Y, Tie J, Wang G, Wu H, et al
    Benefits of TIPS for Patients With Large Ascites Preceding Recurrent or Refractory ascites: A Multicenter Cohort Study.
    J Gastroenterol Hepatol. 2025;40:1574-1585.
    

    >> Share

    
    
35. WANG L, Zhao Y, Duan B, Wang Y, et al
    Iron Quantification Using Spectral CT-Based Material Decomposition Technique for Noninvasive Hepatic Fibrosis Staging: An Experimental Study.
    J Gastroenterol Hepatol. 2025 Jun 4. doi: 10.1111/jgh.17031.
    

    >> Share

    
    
36. NIIZEKI T, Mawatari S, Shibata M, Sasaki R, et al
    Comparison Analysis of Lenvatinib Plus Transcatheter Arterial Chemoembolization Versus Atezolizumab Plus Bevacizumab as First-Line Therapy for Intermediate-Stage Hepatocellular Carcinoma Beyond the Up-to-Seven Criteria.
    J Gastroenterol Hepatol. 2025 May 31. doi: 10.1111/jgh.17024.
    

    >> Share

    
    

    
    J Hepatol

37. TAKEFUJI Y
    Reevaluating Feature Selection in Machine Learning-Based Radiomics for Hepatocellular Carcinoma: Bridging the Gap Between Predictive Accuracy and Biological Relevance.
    J Hepatol. 2025 May 29:S0168-8278(25)02258-5. doi: 10.1016/j.jhep.2025.
    

    >> Share

    
    

    
    N Engl J Med

38. SIMON TG
    Semaglutide for Metabolic Dysfunction-Associated Steatohepatitis.
    N Engl J Med. 2025;392:2160-2161.
    

    >> Share

    
    

    
    PLoS One

39. YOON J, Lee Y, Yoon S, Sung J, et al
    Deep learning reconstruction of free-breathing, diffusion-weighted imaging of the liver: A comparison with conventional free-breathing acquisition.
    PLoS One. 2025;20:e0320362.
    

    >> Share

    
    
40. RONG F, Cheng B, Guo L, Zeng S, et al
    Correlation analysis of mitochondrial DNA maintenance-related genes with HCC prognosis, tumor mutation burden and tumor microenvironment features.
    PLoS One. 2025;20:e0325033.
    

    >> Share

    
    
41. GRAF M, Graf C, Ziegelmayer S, Marka AW, et al
    Complications of image-guided liver biopsies: Results of a nationwide database analysis.
    PLoS One. 2025;20:e0323695.
    

    >> Share

    
    
42. YOO HW, Yang CJ, Yoo JJ, Chang Y, et al
    Diagnostic performance of microvascular flow imaging for noninvasive assessment of liver fibrosis in chronic liver disease.
    PLoS One. 2025;20:e0322102.
    

    >> Share

    
    
43. WU C, Chen X, Zhang Y, Du Y, et al
    A novel ferroptosis-related signature for predicting prognosis, immune characteristics, and treatment prediction in hepatocellular carcinoma.
    PLoS One. 2025;20:e0322158.
    

    >> Share

    
    
44. WEI B, Zheng Y, Yu S, Wang A, et al
    Identification of key genes and signaling pathways of liver cancer and model construction for prognosis and diagnosis based on bioinformatics analysis.
    PLoS One. 2025;20:e0325610.
    

    >> Share

    
    
45. LEE CW, Kang ES, Jeong S, Han HW, et al
    Identification of potentially effective drugs for metabolic dysfunction-associated steatotic liver disease against liver cirrhosis: In-silico drug repositioning-based retrospective cohort study.
    PLoS One. 2025;20:e0323880.
    

    >> Share

    
    
46. MARGULIES BS, Likhitpanichkul M, Tripathy D
    Reshaping the landscape of locoregional treatments for breast cancer liver metastases: A novel, intratumoral, p21-targeted percutaneous therapy increases survival in BALB/c mice inoculated with 4T1 triple negative breast cancer cells in the liver.
    PLoS One. 2025;20:e0323621.
    

    >> Share

    
    
47. ORRIOLS G, Aljama C, Rodriguez-Frias F, Medina PG, et al
    Quantification of serum elastase inhibitory activity in patients with pulmonary emphysema with and without alpha-1 antitrypsin deficiency.
    PLoS One. 2025;20:e0324237.
    

    >> Share

    
    

    
    Radiol Imaging Cancer

48. LI M, Zhang Z, Chen Z, Chen X, et al
    Interactive Explainable Deep Learning Model for Hepatocellular Carcinoma Diagnosis at Gadoxetic Acid-enhanced MRI: A Retrospective, Multicenter, Diagnostic Study.
    Radiol Imaging Cancer. 2025;7:e240332.
    

    >> Share

    
    
49. SINGH Y, Gores GJ, Erickson BJ
    Beyond the Black Box: Explainable AI Transforms Hepatocellular Carcinoma Diagnosis at MRI.
    Radiol Imaging Cancer. 2025;7:e250198.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share